company background image
BIOHLDG logo

Bioalpha Holdings Berhad KLSE:BIOHLDG Stock Report

Last Price

RM0.085

Market Cap

RM126.6m

7D

0%

1Y

-29.2%

Updated

18 Apr, 2024

Data

Company Financials

Bioalpha Holdings Berhad

KLSE:BIOHLDG Stock Report

Market Cap: RM126.6m

BIOHLDG Stock Overview

Bioalpha Holdings Berhad, an investment holding company, researches, develops, manufactures, distributes, and trades in nutritional and health supplement products in Malaysia, China, Indonesia, and internationally.

BIOHLDG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Bioalpha Holdings Berhad Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bioalpha Holdings Berhad
Historical stock prices
Current Share PriceRM0.085
52 Week HighRM0.14
52 Week LowRM0.08
Beta2.11
1 Month Change0%
3 Month Change-19.05%
1 Year Change-29.17%
3 Year Change-60.47%
5 Year Change-59.52%
Change since IPO-57.53%

Recent News & Updates

Recent updates

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Mar 19
Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Oct 04
Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Jun 20
Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Mar 01
Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching

Mar 29
Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Mar 03
Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?

Jan 20
Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?

How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?

Nov 28
How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?

Shareholder Returns

BIOHLDGMY Personal ProductsMY Market
7D0%-1.1%-1.1%
1Y-29.2%7.3%9.5%

Return vs Industry: BIOHLDG underperformed the MY Personal Products industry which returned 7.3% over the past year.

Return vs Market: BIOHLDG underperformed the MY Market which returned 9.5% over the past year.

Price Volatility

Is BIOHLDG's price volatile compared to industry and market?
BIOHLDG volatility
BIOHLDG Average Weekly Movement9.8%
Personal Products Industry Average Movement4.4%
Market Average Movement5.1%
10% most volatile stocks in MY Market11.1%
10% least volatile stocks in MY Market2.5%

Stable Share Price: BIOHLDG's share price has been volatile over the past 3 months.

Volatility Over Time: BIOHLDG's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of MY stocks.

About the Company

FoundedEmployeesCEOWebsite
2005n/aWilliam Honbioa.com.my

Bioalpha Holdings Berhad, an investment holding company, researches, develops, manufactures, distributes, and trades in nutritional and health supplement products in Malaysia, China, Indonesia, and internationally. It operates through Trading, Manufacturing, Retail Pharmacy, and Others segments. The company engages in the provision of advertising and promotion services for health supplements, nutrition products, personal care, functional foods, and healthcare products; import, export, cultivation, manufacturing, distribution, and trading of various agro products and medical herbs; and planting, growing, trading of herbs, fruits, agricultural, and agro and organic products.

Bioalpha Holdings Berhad Fundamentals Summary

How do Bioalpha Holdings Berhad's earnings and revenue compare to its market cap?
BIOHLDG fundamental statistics
Market capRM126.58m
Earnings (TTM)-RM38.55m
Revenue (TTM)RM46.08m

2.6x

P/S Ratio

-3.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOHLDG income statement (TTM)
RevenueRM46.08m
Cost of RevenueRM46.32m
Gross Profit-RM231.00k
Other ExpensesRM38.32m
Earnings-RM38.55m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.027
Gross Margin-0.50%
Net Profit Margin-83.65%
Debt/Equity Ratio4.6%

How did BIOHLDG perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.